BioMarin Pharma (BMRN) – Momentum Movers
-
Sarepta Therapeutics (SRPT) Says USPTO Issued Favorable Decisions on Exon 51 and Exon 53 Composition in Case vs BioMarin (BMRN)
-
Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer
-
-
-
-
-
-
-
-
-
-
-
Back to BMRN Stock Lookup